ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2258

Role of NLRP12 on Disease Severity in Autoimmune Arthritis

Ryan Lupo and Peng Liu, Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: innate immunity and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Innate Immunity and Rheumatic Disease - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are cytoplasmic sensors that response to danger signals released by invading pathogen or self-damaged tissues. NLRP12 is a member of the NLR protein family and classified as a negative regulator of inflammation and autoimmune response. However, the role of NLRP12 for autoimmune arthritis has not been explored. To investigate the NLRP12 effect on rheumatoid arthritis (RA), we decided to study whether NLRP12 deficiency would have an impact on disease outcome using the RA model of collagen-induced arthritis (CIA).

Methods:  C57BL/6 Nlrp12-/-mice were obtained from Dr. Jenny Ting’s laboratory and backcrossed onto DBA/1J background for eleven generations. These mice and wild type (WT) mice were induced with CIA. Arthritis development was monitored for 45 days, and joint samples were harvested for histological analysis and RT-PCR detection of cytokine production in the joints.

Results:  We found that Nlrp12-/- mice show reduced clinical scores and diminished paw swelling compared to WT mice throughout disease development. Histological joint sections of Nlrp12-/- mice show a decrease in immune cell infiltration to the synovial membrane and space, reduced cartilage damage, and less bone erosion. Then we examined the cytokine expression in the joints of Nlrp12-/- mice and found that the proinflammatory cytokines IL-1beta and IL-6 were substantially reduced compared to WT mice, whereas TNFalpha and IL-17 expressions remain similar between Nlrp12-/- mice and WT mice.

Conclusion:  Our results indicate that NLRP12 deficiency reduces autoimmune arthritis in the CIA model by decreased inflammation and proinflammatory cytokines in the joints. Further studies are needed to identify the innate immune cells and the molecular pathways in which NLRP12 functions in autoimmune arthritis as they could lead to potential therapeutic targets for patients with RA.


Disclosure: R. Lupo, None; P. Liu, None.

To cite this abstract in AMA style:

Lupo R, Liu P. Role of NLRP12 on Disease Severity in Autoimmune Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/role-of-nlrp12-on-disease-severity-in-autoimmune-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-nlrp12-on-disease-severity-in-autoimmune-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology